Patents by Inventor Christophe Lamarque

Christophe Lamarque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucose Uptake Inhibitors
    Publication number: 20240360085
    Abstract: This invention provides compounds that modulate glucose uptake activity and cellular transport/uptake of glucose, and particularly GLUT3, but also including but not limited to GLUT1-14 (SLC2A1-SLC2A14). Compounds of the invention are useful for treating diseases, including cancer, autoimmune diseases and inflammation, infectious diseases, and metabolic diseases.
    Type: Application
    Filed: May 23, 2024
    Publication date: October 31, 2024
    Applicant: Kadmon Corporation, LLC
    Inventors: Kevin G. Liu, Kellen Olszewski, Ji-In Kim, Masha V. Poyurovsky, Koi Morris, Xuemei Yu, Christophe Lamarque
  • Glucose uptake inhibitors
    Patent number: 12030857
    Abstract: This invention provides compounds that modulate glucose uptake activity and cellular transport/uptake of glucose, and particularly GLUTS3, but also including but not limited to GLUT1-14 (SLC2A1-SLC2A14). Compounds of the invention are useful for treating diseases, including cancer, autoimmune diseases and inflammation, infectious diseases, and metabolic diseases.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: July 9, 2024
    Assignee: Kadmon Corporation, LLC
    Inventors: Kevin G. Liu, Kellen L. Olszewski, Ji-In Kim, Masha V. Poyurovsky, Koi Morris, Xuemei Yu, Christophe Lamarque